ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Price-to-Operating-Cash-Flow : (As of Jun. 02, 2024)

View and export this data going back to 2016. Start your Free Trial

What is ExpreS2ion Biotech Holding AB Price-to-Operating-Cash-Flow?

As of today (2024-06-02), ExpreS2ion Biotech Holding AB's share price is kr1.28. ExpreS2ion Biotech Holding AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was kr-1.24. Hence, ExpreS2ion Biotech Holding AB's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for ExpreS2ion Biotech Holding AB's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 11 years, ExpreS2ion Biotech Holding AB's highest Price-to-Operating-Cash-Flow Ratio was 53.40. The lowest was 6.63. And the median was 8.96.

OSTO:EXPRS2's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.775
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

ExpreS2ion Biotech Holding AB's Cash Flow from Operations per share for the three months ended in Mar. 2024 was kr0.02. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was kr-1.24.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -52.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -27.20% per year.

During the past 11 years, ExpreS2ion Biotech Holding AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 8.10% per year. The lowest was -52.90% per year. And the median was -13.80% per year.

ExpreS2ion Biotech Holding AB Price-to-Operating-Cash-Flow Historical Data

The historical data trend for ExpreS2ion Biotech Holding AB's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ExpreS2ion Biotech Holding AB Price-to-Operating-Cash-Flow Chart

ExpreS2ion Biotech Holding AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

ExpreS2ion Biotech Holding AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of ExpreS2ion Biotech Holding AB's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, ExpreS2ion Biotech Holding AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ExpreS2ion Biotech Holding AB's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ExpreS2ion Biotech Holding AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ExpreS2ion Biotech Holding AB's Price-to-Operating-Cash-Flow falls into.

ExpreS2ion Biotech Holding AB Price-to-Operating-Cash-Flow Calculation

ExpreS2ion Biotech Holding AB's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	1.28	/	-1.244
	=

ExpreS2ion Biotech Holding AB's Share Price of today is kr1.28.
ExpreS2ion Biotech Holding AB's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.24.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

ExpreS2ion Biotech Holding AB Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of ExpreS2ion Biotech Holding AB's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

5JD:Germany

Address

c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, S-252 25

Website

https://www.expres2ionbio.com

ExpreS2ion Biotech Holding AB has developed a technology platform, ExpreS2, for fast and efficient non-clinical development and production of complex proteins for new vaccines and diagnostics. ExpreS2 is regulatorily validated for clinical supply. The platform includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. The company has produced more than 500 proteins and virus-like particles (VLPs) in collaboration with research institutions and companies.

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Headlines

No Headlines